This article looked at almost 2000 patients that underwent either a gastric bypass or sleeve gastrectomy and compared them to close to 2000 patients that received a GLP one agonist between 2010 and 2017. At baseline the average age was approximately six years older than those individuals that had drug treatment, which is certainly something to be of concern when evaluating the study. Individuals that ended up getting surgery had lower mortality rate and lower cardiovascular rate at 10 years of f